Related Experiment Videos
Enhanced Ca2(+)-dependent proteolysis associated with Adriamycin-resistant HL-60 cells
A Aquino1, M Johnson-Thompson, R I Glazer
1Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Summary
Multidrug-resistant cells exhibit a unique calcium-dependent protease activity. This protease generates specific phosphoproteins and alters protein levels, distinguishing them from normal cells.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Pharmacology
Background:
- Adriamycin-resistant HL-60 (HL-60/ADR) cells exhibit high levels of M-kinase, a fragment of protein kinase C.
- M-kinase activity leads to the in vitro generation of pp130 in these resistant cells.
Purpose of the Study:
- To investigate the presence and activity of proteases in Adriamycin-resistant HL-60 cells compared to wild-type cells.
- To characterize the role of calcium-activated proteases in the phenotype of multidrug resistance.
Main Methods:
- Analysis of cell extracts from HL-60/ADR and wild-type HL-60 cells.
- In vitro assays to detect protease activity and protein generation.
- Use of protease inhibitors, specifically leupeptin, to block enzymatic activity.
- Metabolic labeling and in vivo studies to assess phosphoprotein levels.
Main Results:
- A Ca2(+)-activated protease was identified in HL-60/ADR cell extracts, absent in wild-type cells.
- This protease generated 26 kDa and 86 kDa phosphoproteins (pp26, pp86) in vitro and reduced pp130 levels.
- Leupeptin inhibited the formation of pp26 and pp86 and the reduction of pp130.
- Elevated phosphorylation of pp26 was observed in resistant cells both in vitro and in vivo.
Conclusions:
- Ca2(+)-dependent protease activity is a distinguishing characteristic of this multidrug-resistant cell line.
- This protease activity contributes to the altered phosphoprotein profile observed in resistant cells.
- The findings suggest a potential role for this protease in the mechanisms of multidrug resistance.